Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asciminib Frontline Risk Adapted

NCT07804901 is registered in ClinicalTrials.gov with Prof. Dr. med. Andreas Hochhaus as lead sponsor.

NCT NCT07804901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asciminib Frontline Risk Adapted
Lead sponsor
Prof. Dr. med. Andreas Hochhaus
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
June 30, 2031
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml)